Abstract 366: CDK7 inhibition as a synthetic lethal strategy in Rb-deficient ER+/HER2- breast cancer and sarcoma cells resistant to CDK4/6 inhibitors
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409689685
